Ramipril Capsule
Product Images NDC 50090-6829

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 50090-6829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906829)

Ramipril 10 mg capsule label from A-S Medication Solutions. The label displays product name, strength, dosage form, storage instructions at 68 to 77 degrees Fahrenheit, and quantity of 90 capsules. Includes the product NDC 50090-6829 and labeler information from Libertyville, Illinois.*

FDA Label Image

Figure 1. Kaplan-meier Estimates Of The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes In The Ramipril Group And The Placebo Group (Ramipril Fig1)

Line graph comparing the proportion of patients over days of follow-up between Ramipril treatment and placebo groups. The x-axis represents days of follow-up up to about 1600 days, and the y-axis shows the proportion of patients up to 0.20. The graph shows higher patient proportion in the placebo group compared to Ramipril, with a significance indicator of P=0.0001.*

FDA Label Image

Figure 2. The Beneficial Effect Of Treatment With Ramipril On The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes Overall And In Various Subgroups (Ramipril Fig2)

A forest plot chart illustrating the relative risk in the Ramipril group compared to placebo across various patient subgroups, including overall population, cardiovascular disease status, diabetes, age, sex, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The chart includes the number of patients and incidence rates in the placebo group, with confidence intervals shown for each relative risk estimate.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure diagram of the active ingredient Ramipril. The image shows the molecular arrangement including rings and functional groups typical of Ramipril's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.